Author Question: The device that will prevent early airway closure is: a. incentive spirometry. b. intermittent ... (Read 54 times)

cookcarl

  • Hero Member
  • *****
  • Posts: 539
The device that will prevent early airway closure is:
 
  a. incentive spirometry.
  b. intermittent positive-pressure breathing.
  c. flutter valve therapy.
  d. high-frequency chest wall oscillation.

Question 2

What is the function of the counterweight plug and magnet in the Acapella Flutter type of de-vice?
 
  a. Creates positive and negative pressure in the chest
  b. Provides high-frequency external chest wall oscillations
  c. Creates oscillations that are transmitted into the lungs
  d. Creates positive pressure throughout the respiratory cycle



mcinincha279

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

ANS: C
The steel ball of the flutter valve or the counterweighted plug and magnet help to prevent early airway closure.

Answer to Question 2

ANS: C
Acapella is a flutter type of valve that creates a series of high-frequency oscillations that are transmitted into the lungs through the airway opening.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

For a complete list of videos, visit our video library